Thiol Isomerases During Thrombus Formation
血栓形成过程中的硫醇异构酶
基本信息
- 批准号:7727782
- 负责人:
- 金额:$ 45.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:Alpha GranuleAnimal ModelAntibodiesAppearanceBindingBiochemicalBlood PlateletsCell membraneCell surfaceCharacteristicsCollagenConfocal MicroscopyDiseaseElectron MicroscopyElectron TransportEndoplasmic ReticulumEndothelial CellsEnzymesEquilibriumExtracellular ProteinFamilyFibrinFlow CytometryGenerationsHemostatic AgentsHemostatic functionImmunofluorescence MicroscopyIn VitroInjuryIntegrinsInterventionIsomeraseKineticsKnowledgeLabelLaser injuryLasersLifeLiteratureMass Spectrum AnalysisMembraneMembrane ProteinsMethodsModelingMonitorMorbidity - disease rateMusOrganellesOxidation-ReductionP-SelectinPlatelet ActivationPlayProcessPropertyProtein BiosynthesisProtein Disulfide IsomeraseProteinsRegulationReportingResearchResearch DesignRestRoleSchemeSiteStrokeSulfhydryl CompoundsSurfaceTestingTherapeutic EmbolizationThrombinThromboplastinThrombosisThrombusTwo-Dimensional Gel ElectrophoresisUnited StatesVWF geneatherothrombosisdesigndisulfide bondendoplasmic reticulum glycoprotein p72extracellularferric chloridein vivomembermortalitynoveloxidationprotein functionpublic health relevancerelease of sequestered calcium ion into cytoplasmresearch studytool
项目摘要
DESCRIPTION (provided by applicant): Thiol isomerases are critical for disulfide bond formation during protein synthesis within the endoplasmic reticulum, but protein thiol isomerases located outside of the endoplasmic reticulum may be critical for regulation of redox-sensitive allosteric disulfide bonds in proteins. Thiol isomerases in platelets and endothelial cells may play an important role in the regulation of protein function during thrombus formation. Our hypothesis is that each thiol isomerase that putatively influences thrombus formation in vivo has a specific function on a specific substrate(s). Protein disulfide isomerase and members of the PDI family will be identified in resting platelets and unstimulated endothelial cells, and localized to either the cell surface or internal organelles, or both, by flow cytometry, immunofluorescence microscopy and electron microscopy. The redistribution of thiol isomerases during platelet activation and endothelial cell stimulation, with special focus on the release of the enzymes and their binding to the cell surface, will be explored. To identify potential thiol isomerase substrates, proteins expressing free thiols on the surface of platelets and endothelial cells will be labeled, the membranes purified, and these proteins separated by 2D gel electrophoresis using 16-BAC/SDS. These labeled membrane proteins will be identified by mass spectrometry and will represent possible thiol isomerase substrates. To determine the role of thiol isomerases during thrombus formation, the kinetics of expression of thiol isomerases, including PDI, ERp5, ERp54, ERp72, ERp46, ERdj5, TMX and TMX3 will be studied in a live mouse by intravital multichannel widefield and confocal microscopy. The effect on inhibition of each thiol isomerase using antibodies specific for thiol isomerases on platelet activation monitored by calcium mobilization, platelet alpha granule release detected by P-selectin expression, fibrin formation, thrombin activity, platelet accumulation, platelet on/off rates, platelet thrombus embolization, microparticle accumulation, vWF accumulation, TF expression, and collagen exposure will be evaluated in the laser-induced vessel wall injury model and the ferric chloride model in a living mouse. These studies are designed to determine the role of thiol isomerases released from platelets and endothelial cells, and their contribution to the modulation of function of proteins involved in thrombosis and hemostasis, including but not limited to GPIb, GPIIbIIIa and tissue factor. PUBLIC HEALTH RELEVANCE: Evidence is mounting that important steps in the process of thrombus formation are regulated by the oxidation states of labile disulfide bonds in critical hemostatic proteins. The oxidation state of these bonds is regulated by an enzyme(s) of the thiol isomerase family. The central hypothesis of the proposed research is that specific thiol isomerases act on specific substrates critical to thrombus formation and thus regulate the thrombotic balance. The experiments described in the Research Design and Methods section of this proposal are designed to test this hypothesis. Establishment of a role for thiol isomerases in regulation of thrombus formation could provide novel targets for intervention in thrombotic disorders, atherothrombosis, stroke and thromboembolic disease, major causes of morbidity and mortality in the United States.
描述(由申请人提供):硫醇异构酶对于内质网中蛋白质合成过程中二硫键键的形成至关重要,但是位于内质网外的蛋白质硫醇异构酶可能对调节蛋白质中氧化还原敏感的全科二硫化物的调节可能至关重要。血小板和内皮细胞中的硫醇异构酶在血栓形成过程中的蛋白质功能调节中可能起重要作用。我们的假设是,在体内影响血栓形成的每个硫醇异构酶在特定底物上具有特定功能。蛋白质二硫异构酶和PDI家族的成员将在静息血小板和未刺激的内皮细胞中鉴定,并通过流式细胞仪,免疫荧光显微镜和电子显微镜局部定位于细胞表面或内部细胞器,或两者均定位于细胞表面或内部细胞器。将探索血小板激活和内皮细胞刺激期间硫醇异构酶的重新分布,特别关注酶的释放及其与细胞表面的结合。为了鉴定潜在的硫醇异构酶底物,将标记在血小板和内皮细胞表面上表达游离硫醇的蛋白质,纯化膜,这些蛋白质使用16-BAC/SDS被2D凝胶电泳分离。这些标记的膜蛋白将通过质谱法鉴定,并代表可能的硫醇异构酶底物。为了确定硫醇异构酶在血栓形成过程中的作用,将通过Intravital Multichnel Multichnel广场广场和共振核显微镜在活小鼠中研究硫醇异构酶表达的动力学,包括PDI,ERP5,ERP54,ERP72,ERP72,ERP46,ERP46,ERDJ5,TMX和TMX3。 The effect on inhibition of each thiol isomerase using antibodies specific for thiol isomerases on platelet activation monitored by calcium mobilization, platelet alpha granule release detected by P-selectin expression, fibrin formation, thrombin activity, platelet accumulation, platelet on/off rates, platelet thrombus embolization, microparticle accumulation, vWF accumulation, TF expression, and collagen exposure will be在激光诱导的血管壁损伤模型和活小鼠中的氯化铁模型中进行了评估。这些研究旨在确定从血小板和内皮细胞释放的硫醇异构酶的作用,以及它们对参与血栓形成和止血的蛋白质调节的贡献,包括但不限于GPIB,GPIIBIIIA和组织因子。公共卫生相关性:有证据表明,在临界止血蛋白中,血栓形成过程中的重要步骤受到不稳定二硫键键的氧化状态。这些键的氧化态受硫醇异构酶家族的酶调节。拟议研究的中心假设是特定的硫醇异构酶作用于对血栓形成至关重要的特定底物,从而调节血栓平衡。该提案的研究设计和方法部分中描述的实验旨在检验该假设。建立硫醇异构酶在调节血栓形成中的作用可以为干预血栓性疾病,动脉粥样硬化,中风和血栓栓塞性疾病,美国发病率和死亡率的主要原因提供新的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARBARA C FURIE其他文献
BARBARA C FURIE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARBARA C FURIE', 18)}}的其他基金
STRUCTURAL STUDY OF HEMATOLOGY-RELATED PROTEINS
血液学相关蛋白质的结构研究
- 批准号:
7955099 - 财政年份:2009
- 资助金额:
$ 45.14万 - 项目类别:
STRUCTURAL STUDY OF HEMATOLOGY-RELATED PROTEINS
血液学相关蛋白质的结构研究
- 批准号:
7721234 - 财政年份:2008
- 资助金额:
$ 45.14万 - 项目类别:
STRUCTURAL STUDY OF HEMATOLOGY-RELATED PROTEINS
血液学相关蛋白质的结构研究
- 批准号:
7369525 - 财政年份:2005
- 资助金额:
$ 45.14万 - 项目类别:
相似国自然基金
TLR4调控系统性红斑狼疮中自身反应性B-1a细胞活化的作用及机理研究
- 批准号:81901635
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
IL-17促进系统性红斑狼疮发病中浆细胞功能的机制研究
- 批准号:81771761
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
中东呼吸综合征新型人源应急救治单克隆抗体保护作用机制研究
- 批准号:81772191
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
肺腺癌中Timp-1促癌机制的研究及其阻断抗体的运用
- 批准号:81672268
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
抗磷脂抗体诱导中性粒细胞释放NETs致抗磷脂综合征肾病的机制研究
- 批准号:81671589
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
I 期临床试验测试使用血小板因子 VIII 的造血干细胞基因治疗通过抑制性抗体安全改善严重甲型血友病止血的可行性
- 批准号:
10388261 - 财政年份:2019
- 资助金额:
$ 45.14万 - 项目类别:
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
I 期临床试验测试使用血小板因子 VIII 的造血干细胞基因治疗通过抑制性抗体安全改善严重甲型血友病止血的可行性
- 批准号:
10599276 - 财政年份:2019
- 资助金额:
$ 45.14万 - 项目类别:
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
I 期临床试验测试使用血小板因子 VIII 的造血干细胞基因治疗通过抑制性抗体安全改善严重甲型血友病止血的可行性
- 批准号:
9908183 - 财政年份:2019
- 资助金额:
$ 45.14万 - 项目类别:
Biology and Application of Platelet-Delivered Factor VIII
血小板递送因子VIII的生物学和应用
- 批准号:
9264016 - 财政年份:2016
- 资助金额:
$ 45.14万 - 项目类别:
Intraosseous delivery of lentiviral vectors for hemophilia A gene therapy
用于血友病 A 基因治疗的慢病毒载体骨内递送
- 批准号:
9195405 - 财政年份:2016
- 资助金额:
$ 45.14万 - 项目类别: